Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Antiplatelet Resistance in Stent Patients
NCT00589862Phase 4Withdrawn
- Sponsor
- Creighton University
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in coronary artery disease (CAD), sponsored by Creighton University. Primary endpoint: Frequency of aspirin and Plavix (Clopidogrel) resistance at 12 months. Planned start Oct 2007; status: withdrawn.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00589862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589862.